Setting up econometric ARIMA methodology to elucidate European Union nosocomial antimicrobial resistance rate trend evolution based on largest EU database

Econometric ARIMA model statistically proved slowdowns and reversions in increase trend of nosocomial E. coli and K. pneumoniae resistance to 3GC and FQ, as well as in resistance of P. aeruginosa resistance to 3GC. P. aeruginosa resistance to FQ shows a descending slope. These brakes and decreased trends proved constitute noteworthy milestones in tackling AMR in Europe.